The biological starting point is a channel protein that vascular biologists have studied for decades. In the smooth muscle cells of cerebral arteries, calcium- and voltage-gated potassium channels of large conductance, known as BK channels, act as a built-in brake on contraction. When calcium rises inside a contracting myocyte, BK channels open and release potassium, which repolarizes the membrane, relaxes the muscle cell and keeps the artery open. Alcohol disrupts this safety mechanism. By inhibiting BK channels in cerebrovascular smooth muscle, alcohol allows the arteries to constrict, reducing blood flow to brain tissue, a response that has been proposed to contribute to the elevated stroke risk seen after heavy drinking episodes.

Over the years, the Memphis group made a series of counterintuitive observations. A high-cholesterol diet, far from worsening alcohol’s cerebrovascular effects, actually protected rats against alcohol-induced constriction of cerebral arteries. More recently, they found that oral supplementation with docosahexaenoic acid, or DHA, the omega-3 fatty acid abundant in fish oil, offered similar protection in males. That raised an obvious question: if both interventions work, do their effects stack? To find out, the researchers, led by Shiwani Thapa, Steven Mysiewicz, Alex Dopico and Anna Bukiya, combined the two protective strategies in the same animals and asked whether the combined benefit exceeded either one alone.

The in vivo experiments used Sprague-Dawley rats maintained on a high-cholesterol diet for 18 weeks, long enough to significantly raise both blood lipids and cholesterol content within the artery walls themselves. Half of the animals also received daily oral DHA at 14 milligrams per kilogram of body weight, while controls received an equivalent volume of water. The team then implanted a cranial window over branches of the middle cerebral artery, threaded a catheter into the carotid artery to deliver alcohol directly into the cerebral circulation, and filmed the pial arterioles every minute under a microscope. Alcohol was infused at 50 millimolar, a concentration corresponding to the moderate-to-heavy drinking range and roughly three times the legal driving limit in most of the United States.

The results were unambiguous. In males on the high-cholesterol diet alone, the fold-change in arteriole diameter nine minutes after alcohol infusion averaged 1.13, statistically indistinguishable from baseline fluctuations, meaning the arteries essentially refused to constrict. Adding DHA changed nothing meaningful: the fold-change was 0.95, not significantly different from the control group. Females showed the same pattern, with values of 1.12 and 1.04 respectively. If cholesterol and DHA acted on separate targets, the combination should have produced at least some additional benefit. Instead, the effect plateaued, a classic ceiling signature suggesting that both lipids converge on a shared mechanism that, once engaged, cannot be engaged further.

To rule out systemic confounders, the team repeated the logic in isolated arteries. Pressurized middle cerebral arteries from rats were stripped of their endothelium or left intact, enriched with cholesterol using a methyl-beta-cyclodextrin delivery complex, and then bathed in 3 micromolar DHA before being challenged with alcohol concentrations spanning 5 to 100 millimolar, from behaviorally relevant doses to sub-lethal levels. Cholesterol enrichment alone abolished alcohol-induced constriction across the entire range in both sexes, and DHA added nothing. Because the outcome was identical with and without a functional endothelium, the shared pathway appears to reside within the smooth muscle cell itself, independent of the circulation and of complex neuronal networks.

The search for that shared target turned to a single amino acid. Previous work from the same laboratory had shown that cholesterol’s protection hinges on tyrosine 450, residue Y450, within the slo1 alpha subunit that forms the BK channel pore. Substituting phenylalanine for tyrosine, the Y450F mutation, disables cholesterol’s protective effect. If cholesterol and DHA truly share a pathway, Y450 should also be required for DHA’s protection. To test this, the researchers turned to genetically engineered knock-in mice carrying the slo1Y450F substitution, bred on a C57BL/6J background alongside wild-type littermates, and pressurized their isolated middle cerebral arteries ex vivo at 60 millimeters of mercury to develop myogenic tone.

In males, the prediction held. In wild-type arteries, alcohol at 50 millimolar constricted vessels by about 1 percent of baseline diameter, and DHA flipped that response to a slight average dilation, a significant protective effect. In arteries from Y450F knock-in males, DHA’s protection vanished entirely: alcohol responses were statistically identical with and without the fatty acid. A two-way analysis of variance revealed a significant interaction between genotype and DHA treatment, confirming that loss of the tyrosine residue, not some background difference between the mouse groups, was responsible for eliminating the protection.

The females told a more surprising story. Wild-type female arteries showed little alcohol-induced constriction to begin with, consistent with earlier reports that vessels from female rodents are consistently less sensitive to alcohol, possibly reflecting differences in BK channel accessory beta1 subunit composition or modulation by female steroid hormones. But in Y450F knock-in females, alcohol produced a pronounced constriction of nearly 3.9 percent, and DHA fully protected against it. In other words, removing tyrosine 450 did not abolish DHA’s protection in females the way it did in males; instead, it unmasked a vulnerability that DHA could still counter through some other, Y450-independent route. The researchers conclude that slo1Y450 functions as a sexually dimorphic sensor within a shared pathway linking alcohol, cholesterol and DHA actions on cerebral artery diameter.

The physiological stakes are considerable. Because blood flow varies with the fourth power of vessel radius under Poiseuille’s law, even a 5 percent change in cerebral artery diameter can reduce perfusion by up to 20 percent, and neuronal function is acutely sensitive to such perturbations. The Tennessee team cautions that these findings come from rodent and mouse models and that the reasons for the sex differences remain unresolved, but the work narrows the molecular landscape considerably: a single tyrosine in a potassium channel emerges as a potential relay station where alcohol’s vasoconstrictive action and two dietary lipids’ protective effects meet. It also delivers a broader message for vascular pharmacology, namely that strategies to blunt alcohol’s cerebrovascular damage may need to be designed, and dosed, differently for men and women.

Subject of Research: Shared molecular pathway by which cholesterol and docosahexaenoic acid protect cerebral arteries against alcohol-induced constriction via the BK channel slo1 Y450 residue

Article Title: Cholesterol and docosahexaenoic acid likely protect against alcohol-induced constriction of cerebral arteries via a common pathway

Article References: Thapa, S., Mysiewicz, S., Dopico, A. M., & Bukiya, A. N. (2026). Cholesterol and docosahexaenoic acid likely protect against alcohol-induced constriction of cerebral arteries via a common pathway. Advances in Drug and Alcohol Research, 6, Article 16302. https://doi.org/10.3389/adar.2026.16302

Image Credits: AI Generated

DOI: 10.3389/adar.2026.16302

Keywords: binge drinking, cerebral arteries, BK channels, cholesterol, docosahexaenoic acid, omega-3, vascular smooth muscle, alcohol, sex differences, ion channels, cerebrovascular dysfunction, slo1 subunit